STUDY QUESTION: Is there a distinct sperm histone-retained epigenetic signature in unexplained male factor infertility patients resulting in compromised blastocyst development?
WHAT IS KNOWN ALREADY: Aberrant sperm DNA methylation has been associated with known male factor infertility, particularly noted in oligozoospermic patients. Unexplained male factor infertility remains a significant proportion of in vitro fertilization failures having unknown underlying physiology.
STUDY DESIGN, SIZE, DURATION: Sperm samples (n = 40) and blastocysts (n = 48) were obtained during fertile donor oocyte IVF cycles with normozoospermic parameters, thereby excluding known female and male infertility factors. Samples were divided into two groups based on blastocyst development (Good Group = ≥20% embryos with D5 grade 'AA' blastocysts, and ≥60% embryos of transferable quality on D5 and D6; Poor Group = ≤10% embryos with D5 grade 'AA' blastocysts, and ≤40% embryos of transferable quality on D5 and D6).
PARTICIPANTS/MATERIALS, SETTING, METHODS: Samples were obtained from patients undergoing IVF treatments with informed consent and institutional review board approval. The Infinium HumanMethylation450 BeadChip microarray was used to identify histone-retained CpG island genes and genomic regions showing differences in sperm DNA methylation between the Good Group and the Poor Group. Pathway and gene network analysis for the significantly altered genes was performed, and targeted DNA methylation validation was completed for 23 genes and two imprinting control regions. Sperm miRNA profiles were assessed using the TaqMan ® Human
MicroRNA Array Card, with corresponding blastocyst mRNA gene expression examined by qRT-PCR.
MAIN RESULTS AND THE ROLE OF CHANCE:
Our study is the first to investigate unexplained male factor infertility while significantly eliminating confounding female factors from our sample population by using only young fertile donor oocytes. We identified 1634 CpG sites located at retained histone CpG island regions that had significant sperm DNA methylation differentials between the two embryogenesis groups (P < 0.05). A largely hypermethylated profile was evident in the Good Group, with a small but distinct and statistically significant shift (P < 0.05) observed in the Poor Group. Genes involved in embryonic development were highly represented among histone-retained CpG sites with decreased methylation in the Poor Group (P < 0.05). Ten significantly altered sperm miRNAs (P < 0.05), correlated with altered target gene mRNA expression in the blastocysts from the Poor Group (P < 0.05). Taken together, significantly impacted sperm miRNA and target transcript levels in blastocysts from the Poor Group may contribute alongside aberrant sperm DNA methylation to the compromised blastocyst development observed.
Introduction
Infertility is a complex disorder encompassing a broad range of physical, structural, hormonal, genetic and environmental causes. It can impact either the male or female counterpart as well as the couple collectively as a pair. While many origins of infertility are well characterized, as many as half (37-58%) of all cases are diagnosed as unexplained, having the standard infertility testing fail to find a cause (Moghissi and Wallach, 1983; Irvine, 1998; Hamada et al., 2012) . The introduction of in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) bypasses male infertility, thus eliminating the majority of barriers to fertilization but concurrently preventing an explanation for their cause. Unexplained (idiopathic) male factor (MF) infertility remains a significant proportion ranging from 6% to 27% of IVF failures having unknown underlying physiology (Moghissi and Wallach, 1983; Hamada et al., 2011) . Epigenetics refers to chromatin modifications, including DNA methylation, histone modifications and non-coding RNAs, that alter the accessibility of genes and regulate gene expression without changes to the DNA sequence (Jaenisch and Bird, 2003) . Sperm epigenetic marks have been implicated in zygotic functions post-fertilization, and may contribute to embryonic development and offspring health (Nanassy and Carrell, 2008; Kumar et al., 2013) . However, the precise epigenetic signature that is heritable in human gametes is still under debate, likewise the function of human sperm epigenetic inheritance in the early embryo remains largely unknown.
During gametogenesis and early embryogenesis the methylome is reprogrammed as genome-wide epigenetic transitions are orchestrated, shifting the embryo into a totipotent state (Rodenhiser and Mann, 2006) . Some regions, like imprinted genes and repetitive elements, can preserve their methylation signature from the parental gametes through to the developing embryo. Additional inheritance from the sperm DNA methylation landscape may be essential for both fertilization of the oocyte and viability of the early embryo Dada et al., 2012; Jenkins and Carrell, 2012) . Non-coding RNAs have been detected in sperm (Pessot et al., 1989; Krawetz, 2005) including microRNAs (Amanai et al., 2006; Yan et al., 2008) . However, the necessity of human sperm-borne RNAs for fertilization and embryogenesis remains under debate (Sendler et al., 2013; Cui et al., 2015) .
Sperm DNA is primarily packaged tightly within the sperm head by protamines (Oliva and Dixon, 1991; Dadoune, 1995) , which is conducive to a largely hypermethylated genome and a transcriptionally silent state. The localization and modification of retained histones (5-15% in humans) may reflect regions important for early embryonic development (Gatewood et al., 1987; Hammoud et al., 2009; Miller et al., 2010) , including developmental genes, transcription factors, microRNAs (miRNAs) and imprinted genes. Abnormal sperm DNA methylation signatures have largely been associated with MF infertility, particularly noted in oligozoospermic patients and observed at imprinted and developmental genes located at retained histones (Hammoud et al., , 2011 . This has led to further investigations of genome-wide sperm epigenetic patterns in MF cases (Houshdaran et al., 2007; Jenkins et al., 2015 Jenkins et al., , 2016a Dere et al., 2016) , and recently expanded to unexplained infertility Urdinguio et al., 2015; Jenkins et al., 2016b) .
As epigenetic aberrations have been highly implicated in known MF infertility, we hypothesize that there is a lesser, but still distinct, abnormal sperm epigenetic signature in unexplained infertility patients resulting in compromised embryogenesis and outcome. The aim of this study was to use DNA methylation analysis of the histone-retained sperm CpG island regions, combined with sperm miRNA profiling, to improve the knowledge of sperm epigenetics and provide evidence for potential causes of unexplained male factor infertility.
Materials and Methods

Ethical approval
Semen samples were obtained from 40 men, and surplus, cryopreserved blastocysts were donated from sixteen couples, that underwent IVF treatments at the Colorado Center for Reproductive Medicine, after informed consent and Institutional Review Board approval.
Sample selection
Semen analysis (n = 40) was performed in accordance with World Health Organization guidelines (Cooper et al., 2010) . Only normozoospermic samples from young donor oocyte IVF cycles were included in the study. Sperm samples (n = 20) were selected for the good quality embryo group ('Good Group'), based on inclusion criteria of ≥20% embryos with D5 grade 'AA' blastocysts, and ≥60% embryos of transferable quality (grade ≥'3BB') on Day 5 and Day 6 collectively. Likewise, sperm samples (n = 20) were selected for the poor quality embryo group ('Poor Group'), based on inclusion criteria of ≤10% embryos with D5 grade 'AA' blastocysts, and ≤40% embryos of transferable quality on Day 5 and Day 6 collectively. Semen samples were prepared by a twolayer (90-45%) PureSperm density-gradient centrifugation (Nidacon, Gothenburg, Sweden) with subsequent swim-up concentrating technique to collect the viable progressively motile portion. A somatic cell lysis step (0.1% SDS, 0.5% Triton X-100 in H 2 O) was employed to remove round cell contamination, and clean motile sperm samples were diluted to 5 × 10 6 sperm and stored at −80°C.
Blastocysts (n = 48) from donor oocyte IVF cycles with normozoospermic parameters were scored based on inner cell mass and trophectoderm quality (Gardner and Schoolcraft, 1999 Value after the ± reflect standard error of the mean. Bold values indicate statistically significant differences between groups. Good Group: n = 25 couples; 20 sperm samples, 24 blastocyst samples. Poor Group: n = 28 couples; 20 sperm samples, 24 blastocyst samples Figure 1 Experimental outline and results summary. Normozoospermia sperm samples in donor oocyte IVF cycles resulted in either good quality (Good Group) or poor quality (Poor Group) embryogenesis. In the Poor Group, aberrant sperm DNA methylation in histone-retained regions was enriched for genes involved in critical developmental pathways and regulatory gene networks, while altered sperm miRNAs corresponded to altered target gene transcript levels in blastocysts, reflecting the poor blastocyst development observed.
Figure 2 Sperm DNA methylation profiles of statistically significant genes for the histone-retained genome and across defined genomic regions.
Mean methylation (β-values) for all significantly altered genes between the Good Group (black lines) and the Poor Group (red lines) distributed into 5% methylation intervals for (A) the histone-retained genome (1634 CpGs), (B-E) hypermethylated genomic regions: 5′UTR (189 CpGs), body (1185
Sperm methylation array analysis
Isolated DNA from sperm samples (n = 12) using the QiaAMP DNA Mini Kit (Qiagen, Valencia CA) was bisulfite converted with the EZ DNA Methylation-Direct Kit (Zymo Research, Irvine CA) for hybridization to an Infinium HumanMethylation450 BeadChip microarray (Illumina, San Diego CA) according to manufacturer's protocols. Beta values (β-values; range 0-1) and significant differential methylation was determined by calculating 'DiffScores' at a significance level of P < 0.05 (GenomeStudio, Illumina). After the removal of SNP containing probes, the β-value distribution was examined for histone-retained regions (Hammoud et al., 2009) Quantitative real-time PCR was performed after preamplification using the TaqMan ® Human MicroRNA Array Card and run on the ABI7900HT Fast Real-Time PCR System. Cycle thresholds were analyzed using RQ Manager 1.2.1 (Life Technologies). The Poor Group was analyzed relative to the Good Group using the internal constant, MammU6. A list of differentially expressed miRNAs was uploaded into miRTarBase (http://mirtarbase.mbc.nctu.edu. tw/) to identify predicted target genes for blastocyst gene expression.
Blastocyst relative mRNA gene expression analysis
Total RNA was isolated from individual blastocysts (n = 48) for analysis of transcript abundance as previously described (Parks et al., 2011) . Samples were treated with RNase-free DNase I (Qiagen), and the High Capacity Reverse Transcription cDNA kit (ThermoFisher Scientific, U.S.A.). Quantitative real-time PCR was performed using the ABI 7300 Real Time PCR System with Power SYBR Green PCR Master Mix (ThermoFisher Scientific). The quantification of seven genes was calculated relative to the housekeeping gene, ACTB (β-actin), which displayed comparatively constant levels of transcription in every sample. The Poor Group was analyzed relative to the Good Group. Expression primers are outlined in Supplementary  Table SII .
Statistical analyses
Significant differential methylation for the sperm methylation array analysis was determined by an Illumina custom algorithm for calculating 'DiffScores' [P-value =1/(10^(ABS(DiffScore)/10))] which employed a Benjamini-Hochberg corrected false discovery rate (FDR) approach for multiple testing correction. The algorithm transforms FDR values by the following equation: [−10log 10 (q-value FDR)], such that a transformed FDR value of 13 = 0.05, 20 = 0.01, 30 = 0.001, and a significance level of 0.05 was employed similar to other recent publications (Urdinguio et al., 2015; Dere et al., 2016) . A power analysis was calculated to detect methylation differences of 2% with a standard deviation of 4%, resulting in a required sample size of 63 in each group to achieve a power of 80%. With the sample size of 6 as available in our two groups for the sperm methylation array, this would translate into an observed power of 14% for this study. Pathway analysis was assessed using DAVID 6.8, where a modified Fisher Exact P-value of P < 0.05 were considered significant GO term enrichment for 'Biological Processes', and a Benjamini value of 0.05 was used to correct enrichment P-values to control false discovery rate. Student's t-test was used to examine significance for targeted sperm methylation validation between groups where P < 0.05 was considered to be statistically significant. The Relative Expression Software Tool (REST 2009) (Qiagen) was used for mRNA and miRNA gene expression analyses. The determined expression ratio was tested for significance by a Pair Wise Fixed Reallocation Randomization Test (Pfaffl et al., 2002) .
Results
Patient outcomes and experimental design
A summary of average patient ages, semen parameters and embryo development can be found in Table I , with an experimental outline and results summary found in Fig. 1 . The IVF cycles were defined as one of two groups, sperm resulting in good quality (Good Group) or poor quality (Poor Group) blastocyst development. The only statistical difference between groups was observed at the blastocyst stage based on the inclusion criteria (D5 grade 'AA': Good = 37%, Poor = 1%; P < 0.001; Transferable quality on D5 and D6: Good = 73%, Poor = 21%; P < 0.001). 
Histone-Retained Sperm DNA Methylation Profiles
The sperm methylation array data resulted in 1634 CpG probe sites that were statistically different between the two groups (P < 0.05) at retained histones ( Fig. 1) (Hammoud et al., 2009) . The β-value distribution was examined for all retained histones, and then separated across defined genomic regions. In the Good Group, a predominantly hypermethylated profile was evident, consistent with previous reports (Smallwood et al., 2011; Dere et al., 2016) , having >40% of all CpG sites presenting with ≥80% methylation (≥0.8 β-value). A small but distinct and statistically significant shift away from expected methylation levels was observed in the samples attained from the Poor Group (P < 0.05) ( Fig. 2A) . This shift was uniformly observed for the Poor Group among specific genomic regions that possessed primarily hypermethylated CpGs (Fig. 2B-E) . By contrast, a primarily hypomethylated profile was observed for the Good Group at CpG islands and regions close to the promoter, having >30% of CpG sites presenting with ≤20% methylation (≤0.2 β-value). A statistically significant shift away from expected methylation levels was observed in the samples attained from the Poor Group (P < 0.05). This shift for the Poor Group was consistent among two genomic regions with primarily hypomethylated CpGs ( Fig. 2F and G) .
Gene ontology and regulatory network analysis
Genes with significant differential methylation at CpG probe sites (P < 0.05) showing increased (576 genes) or decreased (562 genes) methylation in the Poor Group were used for biological process GO term analysis. Genes enriched for cellular adhesion and morphogenesis were significant in both sets, as well as a variety of other cellular development and differentiation processes (P < 0.05) ( Table II , Fig. 1) . Notably, genes enriched for transport and localization were highly represented among those with significantly increased CpG methylation in the Poor Group, while genes involved in embryonic morphogenesis and development were highly represented among those with significantly decreased CpG methylation in the Poor Group. Enriched genes listed in the 'embryo morphogenesis' and 'embryo development' categories highlighted a hypermethylated pattern among the sperm samples in the Good Group, with a small but significant methylation loss for these genes in the Poor Group (P < 0.05) (Fig. 2H) . Interestingly, enriched genes listed in the 'transport' and 'localization' categories highlighted an opposite shift for hypermethylated CpGs (P < 0.05) (Fig. 2I) . The same gene lists for increased and decreased methylation in the Poor Group were targeted for bioinformatics analysis to construct regulatory networks (Fig. 3A and B) . Many pathways were found in common between the two methylation lists, including Akt, Jnk, Creb, NF-kB and MAPK. However, different players within these complexes were either increased or decreased in the Poor Group, impacting the overall gene network function (Supplementary Table SIII) .
Targeted sperm DNA methylation validation
Less than ten percent of known human imprinted genes (7%; 7/97) were represented within the methylation array dataset with at least one significantly altered CpG site (range: 1-3 CpG sites). Likewise, examination of 10 known gametic differentially methylated regions (gDMRs; PLAGL1, GRB10, PEG10, MEST, PEG13, H19, KCNQ1OT1, SNRPN, PEG3, GNAS) did not reveal any aberrant imprinted methylation patterns. This was further confirmed by targeted bisulfite sequencing, observing no statistical difference between groups at two defined imprinting control regions (ICRs), the paternally expressed KCNQ1OT1 ICR and the paternally methylated H19 ICR (Fig. 4) .
Twenty-three genes were also selected for further methylation validation at the individual CpG level. Three distinct patterns of methylation were observed: (i) hypermethylation (80-100%) in both groups, (ii) hypomethylation (0-20%) in both groups and (iii) variable methylation in both groups (Fig. 5) . Two genes were selected for evaluation in a larger cohort of sperm samples on account of their consistent and discernable methylation differential between groups; ANKRD53 and MAPT (Fig. 6 and Supplementary Fig. S1 ).
Figure 4
Representative sperm DNA methylation profiles at two imprinting control regions. A representation of targeted DNA methylation analysis in individual normozoospermic samples (n = 6) at the paternally expressed KCNQ1OT1 ICR; hypomethylated (Good Group: 1.2%; Poor Group: 1.0%), and the paternally methylated H19 ICR; hypermethylated (Good Group: 96.6%; Poor Group: 95.0%). No statistical difference was found between groups. Each line is a unique DNA strand amplified within the sperm sample. Black dots represent methylated CpGs, white dots represent unmethylated CpGs. Sperm ID is indicated below-left of the image. Percent methylation is indicated below-right of the image. Arrows indicate the CpG directly targeted by an Infinium HumanMethylation450 BeadChip probe, none of which were statistically significant between groups in the array dataset.
Sperm microRNA profiling
The miRNA profiles of the two sperm groups were investigated and 10 miRNAs were found to be significantly altered, including one that was exclusively expressed in the sperm from the Good Group (miR-325), and one that was exclusively expressed in the sperm from the Poor Group (miR-873). In addition, five were significantly downregulated (let-7d, miR-371-3p, miR-382, miR-516a-5p, miR-523) , while three were significantly up-regulated (miR-139-5p, miR-29c, miR-520d-5p) in the Poor Group (P < 0.05) (Figs 1 and 7A ).
Blastocyst mRNA gene expression
Targeted mRNA transcript levels in individual blastocysts revealed seven genes with significant alterations in the Poor Group (P < 0.05) (Figs 1 and 7B) . Increased miR-29c in the sperm from the Poor Group negatively targets the de novo methyltransferase enzymes in humans. Significant decreases in both DNMT3A and DNMT3B transcripts were found in the blastocysts from the Poor Group. This miRNA also negatively targets MMP2, a matrix metalloproteinase gene important for implantation, showing significantly reduced expression. Decreased miR-382 negatively targets PTEN, a negative regulator of the P13K/ AKT signaling pathway essential for embryonic gene activation. A corresponding increase in expression of PTEN was observed in the blastocysts from the Poor Group. A significant increase was also identified for TDG, a thymine DNA glycosylase required for defense against genetic mutation and for active DNA demethylation, while significant decreases were detected for the pluripotency gene POU5F1, required for proper preimplantation development, and DNMT1, the methyltransferase enzyme required for DNA methylation maintenance.
Discussion
The molecular mechanisms resulting in male infertility are poorly understood, and a large proportion of cases are deemed unexplained, or idiopathic, as standard testing fails to find a cause. Gametogenesis and early embryogenesis are important stages for genome-wide epigenetic transitions, providing a period in which disruption to normal epigenetic regulatory pathways would greatly affect gamete maturation as well as embryo development. Increasing evidence suggests that sperm DNA methylation is an important mark, with a direct association with poor semen parameters, often manifesting at developmental genes and imprinted regions (Hammoud et al., , 2011 . Similar disturbances to male epigenetic reprogramming may also contribute to unexplained male factor infertility and to the poor embryonic development observed in these cases Urdinguio et al., 2015; Jenkins et al., 2016a,b) . To address the association between unexplained MF infertility and epigenetics, we selected sperm samples having normal semen parameters and young donor oocyte cycles to eliminate known male and female factors.
The histone-retained CpG island regions of the sperm epigenome did not exhibit a statistically significant difference when examined in its entirety between the two groups, which indicated no correlation Figure 5 Sperm DNA methylation validation for both groups at select genes. Targeted DNA methylation analysis in individual normozoospermic samples (n = 6) at 23 genes. Black diamonds represent sperm from the Good Group, and red diamonds represent sperm from the Poor Group. Each diamond is positioned at the average percent methylation for the individual sperm sample. Three methylation patterns are observed: hypermethylation in both groups, hypomethylation in both groups and variable methylation in both groups.
between overall DNA methylation levels and quality of embryos (Benchaib et al., 2005) . Rather, a small (~5-10%) but distinct and statistically significant shift away from the expected methylation profile was observed in correlation with poor blastocyst development. The biological significance of this small methylation shift is still unknown, though existing data suggests that subtle epigenetic changes are associated with complex disease phenotypes (Leenen et al., 2016) , and therefore may have greater translational consequences, resulting in a cumulative effect on fertility and subsequent embryonic developmental capacity.
An even distribution between increased methylation and decreased methylation was observed with poor blastocyst development, in agreement with a previous report (Urdinguio et al., 2015) . Gene ontology analysis revealed an enrichment of genes involved in cellular adhesion and morphogenesis similar to other publications Hammoud et al., 2015; Urdinguio et al., 2015) , as well as expansive processes involving cell development, differentiation and organization. Genes in these pathways impact cell-to-cell interactions including sperm-oocyte fusion, embryonic genome activation, implantation potential and embryonic differentiation. As affirmation, enrichment for genes involved in embryo morphogenesis and development were found to be the utmost significant pathway in the population of CpG sites with decreased methylation. Regulatory networks illustrated a surplus of pathways that were common between the gene lists for increased and decreased methylation. Yet, the genes within these pathways were primarily distinct between lists, indicating that the methylation alterations at these genes are collectively driving the changes observed in the unexplained MF infertility group. Aberrant methylation at these critical genes, impacting the overall gene network function, conceivably leads to the observed compromised embryogenesis.
Three distinct patterns of methylation were observed in the genes selected for validation: hypermethylation, hypomethylation and variable methylation. Sperm resulting in poor blastocyst development appeared to be more prone to increased epigenetic heterogeneity, similar to studies of known MF infertility (Benchaib et al., 2005; Kuhtz et al., 2014; Jenkins et al., 2015; Laurentino et al., 2015) . The biological consequences of these small alterations are unclear, but they may impact the active global DNA demethylation of the paternal genome after fertilization, or disrupt the fidelity of DNA methylation maintenance at vital paternally inherited loci.
Altered sperm methylation correlated with altered paternal miRNA profiles in samples resulting in poor blastocyst development. Mature spermatozoa are transcriptionally quiescent, but lingering transcripts including small non-coding RNAs exist (Amanai et al., 2006; Yan et al., 2008) , and their aberrant presence or absence could be indicative of abnormal development, function, or fertility. Growing evidence indicates a potential role for these paternal miRNAs in early embryo development (Krawetz, 2005) . Increased paternal sperm miRNA levels correlated with higher rates of good-quality embryos, implantation, pregnancy and live birth in unexplained male infertility patients (Cui et al., 2015) . In our study, ten miRNAs were identified as significantly altered in association with poor blastocyst development, with corresponding alterations to target genes involved in embryonic genome activation, blastocyst implantation and DNA methylation. This Figure 7 miRNA and mRNA gene expression changes in the Poor Group. Transcript abundance for (A) sperm miRNA expression, and (B) blastocyst mRNA expression. Normalized fold change relative to the Good Group and to the internal constant MammU6 for miRNA expression, and to the housekeeping gene ACTB for mRNA expression. Statistical significance of P < 0.05 is denoted by an asterisk. dysregulation of sperm-borne miRNAs or their targets may also be a source of the observed compromised blastocyst development.
Epigenetic reprogramming events in both the gametes and the early embryo are designed to prevent epigenetic defects from being inherited. However, erroneous generational epigenetic inheritance of aberrant methylation and miRNA signatures from a compromised sperm population, facilitated by IVF/ICSI, may occur and contribute to gene expression alterations and ultimately poor embryo quality. Having eliminated the influence of female factor infertility by using only young fertile donor oocytes, significantly altered methylation profiles enriched at developmental loci were observed in normozoospermic samples resulting in poor blastocyst development, reflecting a subset of unexplained male factor infertility. The improved knowledge of sperm epigenetics and epigenetic inheritance from studies such as ours have important implications for future generations, while providing evidence for potential causes of unexplained male factor infertility and support modified counseling and clinical management.
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